CICC: Maintains "Outperform" rating on Ping An Good Doctor (01833.HK), target price HK$8.30; adjusted net profit for the first three quarters up 19.5% year-on-year

Zhitong Finance APP has learned that CICC issued a research report stating that it maintains Ping An Good Doctor (01833.HK) with an "Outperform" rating and a target price of HK$8.30, based on DCF valuation, implying 49.3% upside from the current share price. In the first three quarters of 2026, the company achieved revenue of RMB 3.508 billion and net profit of RMB 248 million, up 35.0% year on year; adjusted net profit was RMB 258 million, up 19.5% year on year, with results in line with the bank's expectations. The bank maintains its forecasts for the company's net profit attributable to parent for 2026 and 2027 at RMB 239 million and RMB 385 million, respectively.